MOF Biomarker Preservation: Advanced Molecular Stability Tech

The original patent addressed the poor stability of molecular biomarkers in biological samples during the pre-analytical stage. However, it did not provide solutions for real-time monitoring, decentralized collection and analysis, or personalized medicine applications. This new invention solves these problems by combining MOF encapsulants with cutting-edge technologies.

The new claims introduce the innovative combination of MOF encapsulants with distinct technologies, providing a synergistic effect that enhances the preservation, monitoring, and analysis of biological samples. This integration is non-obvious and goes beyond the original patent's scope.

Alternative embodiments may include the use of different MOF types, varying sensor configurations, or alternative AI algorithms. Variations may also involve the integration of additional technologies, such as robotics or augmented reality, to further enhance the systems and methods.

This invention has significant commercial potential in the biomedical research, clinical diagnosis, and personalized medicine industries. It can enable the development of new diagnostic tools, improve the quality of biospecimens, and facilitate more effective treatment strategies. The market for these systems and methods is substantial, with potential applications in hospitals, research institutions, and pharmaceutical companies.